FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2768055327> ?p ?o ?g. }

• W2768055327 endingPage "266" @default.
• W2768055327 startingPage "261" @default.
• W2768055327 abstract "Objective: To explore the effectiveness of raltegravir-based antiretroviral therapy (ART) on treatment response among ART-naive patients seeking routine clinical care. Design: Cohort study of adults enrolled in HIV care in the United States. Methods: We compared virologic suppression and CD4+ cell count recovery over a 2.5 year period after initiation of an ART regimen containing raltegravir or efavirenz using observational data from a US clinical cohort, generalized to the US population of people with diagnosed HIV. We accounted for nonrandom treatment assignment, informative censoring, and nonrandom selection from the US target population using inverse probability weights. Results: Of the 2843 patients included in the study, 2476 initiated the efavirenz-containing regimen and 367 initiated the raltegravir-containing regimen. In the weighted intent-to-treat analysis, patients spent an average of 74 (95% confidence interval: 41, 106) additional days alive with a suppressed viral load on the raltegravir regimen than on the efavirenz regimen over the 2.5-year study period. CD4+ cell count recovery was also superior under the raltegravir regimen. Conclusion: Patients receiving raltegravir spent more time alive and suppressed than patients receiving efavirenz, but the probability of viral suppression by 2.5 years after treatment was similar between groups. Optimizing the amount of time spent in a state of viral suppression is important to improve survival among people living with HIV and to reduce onward transmission." @default.
• W2768055327 created "2017-11-17" @default.
• W2768055327 creator A5024560316 @default.
• W2768055327 creator A5032398444 @default.
• W2768055327 creator A5032860493 @default.
• W2768055327 creator A5043117381 @default.
• W2768055327 creator A5054161918 @default.
• W2768055327 creator A5067905523 @default.
• W2768055327 creator A5074418085 @default.
• W2768055327 date "2018-01-14" @default.
• W2768055327 modified "2023-09-27" @default.
• W2768055327 title "Virologic suppression and CD4+ cell count recovery after initiation of raltegravir or efavirenz-containing HIV treatment regimens" @default.
• W2768055327 cites W1496840240 @default.
• W2768055327 cites W1903407441 @default.
• W2768055327 cites W1966855461 @default.
• W2768055327 cites W1973540642 @default.
• W2768055327 cites W1974671307 @default.
• W2768055327 cites W1988062692 @default.
• W2768055327 cites W1990828872 @default.
• W2768055327 cites W2030038632 @default.
• W2768055327 cites W2030627771 @default.
• W2768055327 cites W2032800042 @default.
• W2768055327 cites W2068866500 @default.
• W2768055327 cites W2075531822 @default.
• W2768055327 cites W2085405111 @default.
• W2768055327 cites W2087093311 @default.
• W2768055327 cites W2094241860 @default.
• W2768055327 cites W2095645580 @default.
• W2768055327 cites W2107921103 @default.
• W2768055327 cites W2109360985 @default.
• W2768055327 cites W2115179084 @default.
• W2768055327 cites W2116146956 @default.
• W2768055327 cites W2145467751 @default.
• W2768055327 cites W2147210767 @default.
• W2768055327 cites W2150504993 @default.
• W2768055327 cites W2153136696 @default.
• W2768055327 cites W2161993838 @default.
• W2768055327 cites W2176483906 @default.
• W2768055327 cites W2302748448 @default.
• W2768055327 cites W2314461521 @default.
• W2768055327 cites W2325035343 @default.
• W2768055327 cites W2325728922 @default.
• W2768055327 cites W2412012985 @default.
• W2768055327 cites W2442197602 @default.
• W2768055327 cites W2443389227 @default.
• W2768055327 cites W2507576186 @default.
• W2768055327 cites W2619335752 @default.
• W2768055327 doi "https://doi.org/10.1097/qad.0000000000001668" @default.
• W2768055327 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5736462" @default.
• W2768055327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29112076" @default.
• W2768055327 hasPublicationYear "2018" @default.
• W2768055327 type Work @default.
• W2768055327 sameAs 2768055327 @default.
• W2768055327 citedByCount "13" @default.
• W2768055327 countsByYear W27680553272018 @default.
• W2768055327 countsByYear W27680553272019 @default.
• W2768055327 countsByYear W27680553272020 @default.
• W2768055327 countsByYear W27680553272021 @default.
• W2768055327 countsByYear W27680553272022 @default.
• W2768055327 countsByYear W27680553272023 @default.
• W2768055327 crossrefType "journal-article" @default.
• W2768055327 hasAuthorship W2768055327A5024560316 @default.
• W2768055327 hasAuthorship W2768055327A5032398444 @default.
• W2768055327 hasAuthorship W2768055327A5032860493 @default.
• W2768055327 hasAuthorship W2768055327A5043117381 @default.
• W2768055327 hasAuthorship W2768055327A5054161918 @default.
• W2768055327 hasAuthorship W2768055327A5067905523 @default.
• W2768055327 hasAuthorship W2768055327A5074418085 @default.
• W2768055327 hasBestOaLocation W27680553272 @default.
• W2768055327 hasConcept C126322002 @default.
• W2768055327 hasConcept C142462285 @default.
• W2768055327 hasConcept C201903717 @default.
• W2768055327 hasConcept C203014093 @default.
• W2768055327 hasConcept C2777302000 @default.
• W2768055327 hasConcept C2780404665 @default.
• W2768055327 hasConcept C2781413609 @default.
• W2768055327 hasConcept C2781432083 @default.
• W2768055327 hasConcept C2908647359 @default.
• W2768055327 hasConcept C2993143319 @default.
• W2768055327 hasConcept C3013748606 @default.
• W2768055327 hasConcept C71924100 @default.
• W2768055327 hasConcept C72563966 @default.
• W2768055327 hasConcept C99454951 @default.
• W2768055327 hasConceptScore W2768055327C126322002 @default.
• W2768055327 hasConceptScore W2768055327C142462285 @default.
• W2768055327 hasConceptScore W2768055327C201903717 @default.
• W2768055327 hasConceptScore W2768055327C203014093 @default.
• W2768055327 hasConceptScore W2768055327C2777302000 @default.
• W2768055327 hasConceptScore W2768055327C2780404665 @default.
• W2768055327 hasConceptScore W2768055327C2781413609 @default.
• W2768055327 hasConceptScore W2768055327C2781432083 @default.
• W2768055327 hasConceptScore W2768055327C2908647359 @default.
• W2768055327 hasConceptScore W2768055327C2993143319 @default.
• W2768055327 hasConceptScore W2768055327C3013748606 @default.
• W2768055327 hasConceptScore W2768055327C71924100 @default.
• W2768055327 hasConceptScore W2768055327C72563966 @default.
• W2768055327 hasConceptScore W2768055327C99454951 @default.
• W2768055327 hasIssue "2" @default.

• next